UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Randomized Trials Show a Consistent Benefit of Radical Prostatectomy on Mortality Outcomes

The Journal of urology, 2019-12, Vol.202 (6), p.1106-1108

2019

Volltextzugriff (PDF)

Surgery for metastases of renal cell carcinoma: outcome of treatments and preliminary assessment of Leuven-Udine prognostic groups in the targeted therapy era

Scandinavian journal of urology, 2018-11, Vol.52 (5-6), p.419-426

2018

Volltextzugriff (PDF)

Serum tumour associated trypsin inhibitor, as a biomarker for survival in renal cell carcinoma

Scandinavian journal of urology, 2020-09, Vol.54 (5), p.413-419

2020

Volltextzugriff (PDF)

The Impact of Histological Subtype on the Incidence, Timing, and Patterns of Recurrence in Patients with Renal Cell Carcinoma After Surgery—Results from RECUR Consortium

European urology oncology, 2021-06, Vol.4 (3), p.473-482

2021

Volltextzugriff (PDF)

Comparison of serial debulking and cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei of appendiceal origin

International journal of colorectal disease, 2014-08, Vol.29 (8), p.999-1007

2014

Volltextzugriff (PDF)

Spatial immunoprofiling of the intratumoral and peritumoral tissue of renal cell carcinoma patients

Modern pathology, 2021-12, Vol.34 (12), p.2229-2241

2021

Volltextzugriff (PDF)

Carbonic anhydrase II: a novel biomarker for pseudomyxoma peritonei

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2017-03, Vol.125 (3), p.207-212

2017

Volltextzugriff (PDF)

Contemporary treatment of renal tumors: a questionnaire survey in the Nordic countries (the NORENCA-I study)

Scandinavian journal of urology, 2017-09, Vol.51 (5), p.360-366

2017

Volltextzugriff (PDF)

Outcome of surgery for patients with renal cell carcinoma and tumour thrombus in the era of modern targeted therapy

Scandinavian journal of urology, 2016-10, Vol.50 (5), p.380-386

2016

Volltextzugriff (PDF)

Patient Experience of Systematic Versus Fusion Prostate Biopsies

European urology oncology, 2018-08, Vol.1 (3), p.202-207

2018

Volltextzugriff (PDF)

Active surveillance versus initial surgery in the long-term management of Bosniak IIF–IV cystic renal masses

Scientific reports, 2022-06, Vol.12 (1), p.10184-10184, Article 10184

2022

Volltextzugriff (PDF)

Genomic profile of pseudomyxoma peritonei analyzed using next‐generation sequencing and immunohistochemistry

International journal of cancer, 2015-03, Vol.136 (5), p.E282-E289

2015

Volltextzugriff (PDF)

Evolving Clinical Picture of Renal Cell Carcinoma: A Population-Based Study from Helsinki

Urologia internationalis, 2019-06, Vol.102 (4), p.390-398

2019

Volltextzugriff (PDF)

Hand-assisted laparoscopic versus open partial nephrectomy in patients with T1 renal tumor: Comparative perioperative, functional and oncological outcome

Scandinavian journal of urology, 2015-11, Vol.49 (6), p.446-452

2015

Volltextzugriff (PDF)

Associations of PTEN and ERG with Magnetic Resonance Imaging Visibility and Assessment of Non–organ-confined Pathology and Biochemical Recurrence After Radical Prostatectomy

European urology focus, 2021-11, Vol.7 (6), p.1316-1323

2021

Volltextzugriff (PDF)

The tumor and plasma cytokine profiles of renal cell carcinoma patients

Scientific reports, 2022-08, Vol.12 (1), p.13416-13416, Article 13416

2022

Volltextzugriff (PDF)

T and NK cell abundance defines two distinct subgroups of renal cell carcinoma

Oncoimmunology, 2022-12, Vol.11 (1), p.1993042-1993042

2022

Volltextzugriff (PDF)

Expression of CEA, CA19-9, CA125, and EpCAM in pseudomyxoma peritonei

Human pathology, 2016-08, Vol.54, p.47-54

2016

Volltextzugriff (PDF)

Repeat multiparametric MRI in prostate cancer patients on active surveillance

PloS one, 2017-12, Vol.12 (12), p.e0189272-e0189272

2017

Volltextzugriff (PDF)

Multiple components of PKA and TGF-β pathways are mutated in pseudomyxoma peritonei

PloS one, 2017-04, Vol.12 (4), p.e0174898-e0174898

2017

Volltextzugriff (PDF)

Prostate MRI added to CAPRA, MSKCC and Partin cancer nomograms significantly enhances the prediction of adverse findings and biochemical recurrence after radical prostatectomy

PloS one, 2020-07, Vol.15 (7), p.e0235779-e0235779

2020

Volltextzugriff (PDF)

Decision Aids for Prostate Cancer Screening Choice: A Systematic Review and Meta-analysis

JAMA internal medicine, 2019-08, Vol.179 (8), p.1072

2019

Volltextzugriff (PDF)

Clonal heterogeneity influences drug responsiveness in renal cancer assessed by ex vivo drug testing of multiple patient‐derived cancer cells

International journal of cancer, 2019-03, Vol.144 (6), p.1356-1366

2019

Volltextzugriff (PDF)

Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vivo and with patient-derived tumor organoids

Journal for immunotherapy of cancer, 2021-08, Vol.9 (8), p.e003000

2021

Volltextzugriff (PDF)

Low nuclear expression of HIF‐hydroxylases PHD2/EGLN1 and PHD3/EGLN3 are associated with poor recurrence‐free survival in clear cell renal cell carcinoma

Cancer medicine (Malden, MA), 2024-02, Vol.13 (3), p.e6998-n/a

2024

Volltextzugriff (PDF)

1 – 25 von 48

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(48)

Sprache

Englisch
(48)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Randomized Trials Show a Consistent Benefit of Radical Prostatectomy on Mortality Outcomes

Surgery for metastases of renal cell carcinoma: outcome of treatments and preliminary assessment of Leuven-Udine prognostic groups in the targeted therapy era

Serum tumour associated trypsin inhibitor, as a biomarker for survival in renal cell carcinoma

The Impact of Histological Subtype on the Incidence, Timing, and Patterns of Recurrence in Patients with Renal Cell Carcinoma After Surgery—Results from RECUR Consortium

Comparison of serial debulking and cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei of appendiceal origin

Spatial immunoprofiling of the intratumoral and peritumoral tissue of renal cell carcinoma patients

Carbonic anhydrase II: a novel biomarker for pseudomyxoma peritonei

Contemporary treatment of renal tumors: a questionnaire survey in the Nordic countries (the NORENCA-I study)

Outcome of surgery for patients with renal cell carcinoma and tumour thrombus in the era of modern targeted therapy

Patient Experience of Systematic Versus Fusion Prostate Biopsies

Active surveillance versus initial surgery in the long-term management of Bosniak IIF–IV cystic renal masses

Genomic profile of pseudomyxoma peritonei analyzed using next‐generation sequencing and immunohistochemistry

Evolving Clinical Picture of Renal Cell Carcinoma: A Population-Based Study from Helsinki

Hand-assisted laparoscopic versus open partial nephrectomy in patients with T1 renal tumor: Comparative perioperative, functional and oncological outcome

Associations of PTEN and ERG with Magnetic Resonance Imaging Visibility and Assessment of Non–organ-confined Pathology and Biochemical Recurrence After Radical Prostatectomy

The tumor and plasma cytokine profiles of renal cell carcinoma patients

T and NK cell abundance defines two distinct subgroups of renal cell carcinoma

Expression of CEA, CA19-9, CA125, and EpCAM in pseudomyxoma peritonei

Repeat multiparametric MRI in prostate cancer patients on active surveillance

Multiple components of PKA and TGF-β pathways are mutated in pseudomyxoma peritonei

Prostate MRI added to CAPRA, MSKCC and Partin cancer nomograms significantly enhances the prediction of adverse findings and biochemical recurrence after radical prostatectomy

Decision Aids for Prostate Cancer Screening Choice: A Systematic Review and Meta-analysis

Clonal heterogeneity influences drug responsiveness in renal cancer assessed by ex vivo drug testing of multiple patient‐derived cancer cells

Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vivo and with patient-derived tumor organoids

Low nuclear expression of HIF‐hydroxylases PHD2/EGLN1 and PHD3/EGLN3 are associated with poor recurrence‐free survival in clear cell renal cell carcinoma

Suchergebnisse filtern